港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

拨康视云－Ｂ

5.350

+0.1703.28%

成交量：45.40万

成交额：242.09万

市值：44.88亿

市盈率：-3.29

高：5.390

开：5.200

低：5.200

收：5.180

52周最高：9.740

52周最低：4.930

股本：8.39亿

香港流通股本：8.39亿

量比：0.68

换手率：0.05%

股息：- -

股息率：- -

每股收益(LYR):-1.628

净资产收益率：--

总资产收益率：-44.38%

市净率：-1.63

市盈率(LYR):-3.29

市销率: 57.48

数据加载中...

总览公司新闻公告

拨康视云港股IPO每股定价10.1港元预计7月3日上市

《新股》拨康视云(02592.HK)今起招股入场费5,100.9元

阿斯达克财经

新股招股｜拨康视云-B今起招股，一手入场费约5100.94港元

老虎资讯综合

拨康视云港股IPO每股定价10.1港元预计7月3日上市

拨康视云预计7月3日起在香港交易所上市交易。

拨康视云-B(02592.HK)预计7月3日上市引入富策控股及Reynold Lemkins作为基石

拨康视云-B(02592.HK)预计7月3日上市引入富策控股及Reynold Lemkins作为基石

拨康视云-B(02592.HK)6月24日起招股发售价将为每股10.10港元

拨康视云-B(02592.HK)6月24日起招股发售价将为每股10.10港元

新股预览：拨康视云-B(2592.HK)

光大新鸿基

拨康视云通过港交所聆讯，计划募资用于核心产品研发等

新股消息 | 眼科生物科技公司拨康视云通过港交所聆讯，三年累计亏损2.95亿美元

智通财经网

新股消息眼科生物科技公司拨康视云通过港交所聆讯三年累计亏损2.95亿美元

新股消息 | 眼科生物科技公司拨康视云通过港交所聆讯三年累计亏损2.95亿美元

新股消息 | 眼科生物科技公司拨康视云通过港交所聆讯三年累计亏损2.95亿美元

智通财经网

【新股消息 | 眼科生物科技公司拨康视云通过港交所聆讯三年累计亏损2.95亿美元】智通财经APP获悉，据港交所6月20

拨康视云“四闯”港交所背后：四年累亏3.3亿美元，股东“内耗”、产品商业化困局待解

拨康视云“四闯”港交所背后：四年累亏3.3亿美元

拨康视云“四闯”港交所背后：四年累亏3.3亿美元，股东“内耗”、产品商业化困局待解

Cloudbreak Pharma Inc.（拨康视云）通过港交所上市聆讯

每日经济新闻

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02592/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02592","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02592\",,,,,undefined,":{"symbol":"02592","market":"HK","secType":"STK","nameCN":"拨康视云－Ｂ","latestPrice":5.35,"timestamp":1756186472331,"preClose":5.18,"halted":0,"volume":454000,"delay":0,"floatShares":838892874,"shares":838892874,"eps":-1.6282492757697142,"marketStatus":"交易中","change":0.17,"latestTime":"08-26 13:42:05","open":5.2,"high":5.39,"low":5.2,"amount":2420935,"amplitude":0.03668,"askPrice":5.35,"askSize":3000,"bidPrice":5.34,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-1.6282492757697142,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1756195800000},"marketStatusCode":2,"adr":0,"listingDate":1751472000000,"exchange":"SEHK","adjPreClose":5.18,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"volumeRatio":0.675475,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02592\",,,,,undefined,":{"symbol":"02592","floatShares":838892874,"roa":"-44.38%","roe":"--","lyrEps":-1.628249,"volumeRatio":0.675475,"shares":838892874,"dividePrice":0,"high":5.39,"amplitude":0.03668,"preClose":5.18,"low":5.2,"week52Low":4.93,"pbRate":"-1.63","psRate":"57.48","week52High":9.74,"institutionHeld":0,"latestPrice":5.35,"committee":-0.5,"eps":-1.6282492757697142,"divideRate":0,"volume":454000,"delay":0,"ttmEps":-1.6282492757697142,"open":5.2,"prevYearClose":10.1,"prevWeekClose":5.11,"prevMonthClose":5.35,"prevQuarterClose":10.1,"fiveDayClose":5.54,"twentyDayClose":5.6,"sixtyDayClose":10.1,"earningDate":1756396800000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02592\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"02592","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02592\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02592\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02592\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02592","date":"2025-08-25","current":-5.611715,"percent":0.72973,"low":-6.683808,"twenty":-6.312981,"median":-6.000684,"eighty":-5.556503,"high":-5.433303,"avg":-5.949854,"sd":0.371248,"marketCap":4345465087},"quantilePoints":[{"date":"2025-07-04","current":-6.317277,"twenty":-6.610502,"median":-6.500542,"eighty":-6.390583,"marketCap":4915912241},{"date":"2025-07-11","current":-6.166376,"twenty":-6.470405,"median":-6.317277,"eighty":-6.263403,"marketCap":4798467239},{"date":"2025-07-18","current":-6.350904,"twenty":-6.498689,"median":-6.350281,"eighty":-6.263403,"marketCap":4941079027},{"date":"2025-07-25","current":-6.080141,"twenty":-6.48004,"median":-6.306537,"eighty":-6.134066,"marketCap":4731355809},{"date":"2025-08-01","current":-5.497985,"twenty":-6.418895,"median":-6.177156,"eighty":-6.011186,"marketCap":4278353657},{"date":"2025-08-08","current":-5.49809,"twenty":-6.350655,"median":-6.13405,"eighty":-5.65539,"marketCap":4278353657},{"date":"2025-08-15","current":-5.725306,"twenty":-6.343182,"median":-6.058573,"eighty":-5.554248,"marketCap":4446132232},{"date":"2025-08-22","current":-5.53457,"twenty":-6.315129,"median":-6.004685,"eighty":-5.554248,"marketCap":4286742586},{"date":"2025-08-25","current":-5.611715,"twenty":-6.312981,"median":-6.000684,"eighty":-5.556503,"marketCap":4345465087}],"updateTime":1756186925515},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02592\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2545421783","title":"拨康视云港股IPO每股定价10.1港元 预计7月3日上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2545421783","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545421783?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 08:42","pubTimestamp":1750725747,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/K2QAI56F0519QIKK.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/K2QAI56F0519QIKK.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02592"],"gpt_icon":0},{"id":"2545421959","title":"《新股》拨康视云(02592.HK)今起招股 入场费5,100.9元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545421959","media":"阿斯达克财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545421959?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 08:25","pubTimestamp":1750724700,"startTime":"0","endTime":"0","summary":"临床阶段眼科生物科技公司拨康视云-B公布在港首次公开发售详情，计划全球发售6,058.2万股，当中国际配售部分占90%，香港公开发售占10%，发售价为每股10.1元，预料集资近6.12亿元。每手买卖单位500股，入场费约5,100.94元。招股期由今日起至周五止，预计会于7月3日挂牌上市。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20250624083337109_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20250624083337109_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1448680/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02592"],"gpt_icon":0},{"id":"1144400905","title":"新股招股｜拨康视云-B今起招股，一手入场费约5100.94港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1144400905","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144400905?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 08:23","pubTimestamp":1750724632,"startTime":"0","endTime":"0","summary":"申购阶梯：每手500股，入场费5100.94港元。乙组门槛为50万股，申购所需资金约510.09万港元。按发售价10.10港元计算，基石投资者将予认购的发售股份总数将为1772万股发售股份。基石投资者包括富策控股有限公司及The Reynold Lemkins Group  Limited。","market":"hk","thumbnail":"https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"新股招股｜拨康视云-B今起招股，一手入场费约5100.94港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02592"],"gpt_icon":0},{"id":"2545429002","title":"拨康视云港股IPO每股定价10.1港元 预计7月3日上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2545429002","media":"观点机构","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545429002?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 08:22","pubTimestamp":1750724575,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/K2Q9ECNC0519D45U.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/K2Q9ECNC0519D45U.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02592"],"gpt_icon":0},{"id":"2545425187","title":"拨康视云预计7月3日起在香港交易所上市交易。","url":"https://stock-news.laohu8.com/highlight/detail?id=2545425187","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545425187?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 07:19","pubTimestamp":1750720789,"startTime":"0","endTime":"0","summary":"拨康视云预计7月3日起在香港交易所上市交易。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/24071951250174.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1044875133.USD","LU1831875114.USD","LU1048588211.SGD","02592","LU0327786744.USD","BK1610","LU0516422366.SGD","HEXmain","LU0577902611.USD","LU0886674414.USD","LU0251144936.SGD","LU1282649141.HKD","IE00BZ08YR35.GBP","LU0348816934.USD","LU0791591158.USD","LU2257852520.SGD","LU0359201885.HKD","IE00BKZH1Z71.USD","LU0261947096.USD","LU0348814723.USD","LU0918141887.USD","80388","LU0577902371.SGD","LU0634319403.HKD","IE00B3T34201.USD","LU0873338254.USD","LU0648948544.HKD","LU1242518857.USD","LU0918141705.HKD","LU0630378692.HKD","IE00BZ08YT58.USD","BK1521","LU0067412154.USD","SG9999001093.SGD","LU1366334651.USD","LU0762542818.HKD","LU0762540952.USD","LU0084288322.USD","LU0197773160.USD","LU1282649067.USD","LU0348827113.USD","HKXCY","LU1242518931.SGD","LU0607220059.USD","LU0594300419.USD","LU1993786604.SGD","LU0516423174.USD","LU0762541174.USD","LU1105468828.SGD","LU1481107354.HKD","00388"],"gpt_icon":0},{"id":"2545423036","title":"拨康视云-B(02592.HK)预计7月3日上市 引入富策控股及Reynold Lemkins作为基石","url":"https://stock-news.laohu8.com/highlight/detail?id=2545423036","media":"新浪财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545423036?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 06:48","pubTimestamp":1750718886,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/K2Q40O7405568W0A.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/K2Q40O7405568W0A.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02592"],"gpt_icon":0},{"id":"2545342376","title":"拨康视云-B(02592.HK)预计7月3日上市 引入富策控股及Reynold Lemkins作为基石","url":"https://stock-news.laohu8.com/highlight/detail?id=2545342376","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545342376?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 06:47","pubTimestamp":1750718838,"startTime":"0","endTime":"0","summary":"格隆汇6月24日丨拨康视云-B发布公告，公司拟全球发售6058.2万股股份，中国香港发售股份605.85万股，国际发售股份5452.35万股；2025年6月24日至6月27日招股；发售价将为每股发售股份10.10港元，每手买卖单位为500股，建银国际及华泰国际为联席保荐人；预期股份将于2025年7月3日开始在联交所买卖。集团拥有两款核心产品，均为自主开发。基石投资者包括富策控股有限公司及The Reynold Lemkins Group  Limited。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/24064751250137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1583","03347","02592","BK1141","BK1576"],"gpt_icon":0},{"id":"2545423030","title":"拨康视云-B(02592.HK)6月24日起招股 发售价将为每股10.10港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545423030","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545423030?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 06:41","pubTimestamp":1750718471,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/K2Q3K3KR05198ETO.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/K2Q3K3KR05198ETO.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02592"],"gpt_icon":0},{"id":"2545423902","title":"拨康视云-B(02592.HK)6月24日起招股 发售价将为每股10.10港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545423902","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545423902?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 06:37","pubTimestamp":1750718256,"startTime":"0","endTime":"0","summary":"格隆汇6月24日丨拨康视云-B(02592.HK)发布公告，公司拟全球发售6058.2万股股份，中国香港发售股份605.85万股，国际发售股份5452.35万股；2025年6月24日至6月27日招股；发售价将为每股发售股份10.10港元，每手买卖单位为500股，建银国际及华泰国际为联席保荐人；预期股份将于2025年7月3日开始在联交所买卖。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/24063751250119.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02592"],"gpt_icon":0},{"id":"2545476690","title":"新股预览：拨康视云-B(2592.HK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2545476690","media":"光大新鸿基","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545476690?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 00:00","pubTimestamp":1750694400,"startTime":"0","endTime":"0","summary":"公司的历史可追溯至2015年集团成立之时。公司拥有两款核心产品，均为自主开发。预计将能治疗各种中度至重度翼状胬肉。根据弗若斯特沙利文报告，目前全球并无获批的药物用来治疗翼状胬肉，翼状胬肉的现有治疗选择是手术切除。一旦CBT-001 获得批准，有望成为全球首款用来治疗翼状胬肉的药物，通过早期非侵入性治疗控制翼状胬肉的发展，从而减少或推迟手术切除的需要。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624115206a4bab8a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624115206a4bab8a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592"],"gpt_icon":0},{"id":"2545496670","title":"拨康视云通过港交所聆讯，计划募资用于核心产品研发等","url":"https://stock-news.laohu8.com/highlight/detail?id=2545496670","media":"贝多财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545496670?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 16:10","pubTimestamp":1750666208,"startTime":"0","endTime":"0","summary":"来源|贝多财经6月20日，CLOUDBREAK PHARMA INC.通过港交所上市聆讯，并披露了聆讯后招股书。本次报考上市，拨康视云计划将募资金额用于核心产品CBT-001的持续临床研发活动以及注册备案及获批后研究所需资金；持续临床研发活动，包括研发人员及研发活动的成本及开支，以及核心产品CBT-009的注册备案的所需资金等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623163031a4b8822a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623163031a4b8822a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0762541174.USD","IE00BZ08YT58.USD","LU0648948544.HKD","LU0607220059.USD","LU0359201885.HKD","LU0164880469.USD","LU0594300179.USD","LU1282649067.USD","LU0348825331.USD","LU0348827113.USD","LU0898667661.SGD","80388","LU0540923850.HKD","LU0762540952.USD","LU0572944931.SGD","IE00BZ08YS42.EUR","HEXmain","LU0048580855.USD","LU0577902371.SGD","LU0072913022.USD","00388","LU0196878994.USD","LU0348735423.USD","LU0417516738.SGD","LU0359201612.USD","LU1366334578.USD","SG9999001093.SGD","LU0043850808.USD","LU0456846285.SGD","HKXCY","LU0348814723.USD","LU0084288322.USD","LU0577902538.SGD","LU1048588211.SGD","LU1993786604.SGD","LU1282649141.HKD","LU1807302812.USD","IE00BZ08YR35.GBP","LU0048597586.USD","LU0149721374.USD","LU1242518931.SGD","LU0918141887.USD","LU1044874839.SGD","LU0516422440.USD","LU0370786039.SGD","02592","LU1105468828.SGD","LU1282648689.USD","LU2226246903.HKD","LU0650527681.SGD","LU0831093199.SGD"],"gpt_icon":1},{"id":"2545480796","title":"新股消息 | 眼科生物科技公司拨康视云通过港交所聆讯，三年累计亏损2.95亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545480796","media":"智通财经网","labels":["dataReport","analysis"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545480796?lang=zh_cn&edition=fundamental","pubTime":"2025-06-22 11:17","pubTimestamp":1750562275,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据港交所6月20日披露，CLOUDBREAK PHARMA INC.通过港交所上市聆讯，建银国际、华泰国际为其联席保荐人。招股书披露，拨康视云是一间临床阶段眼科生物科技公司，致力于开发各种疗法。财务方面，于往绩记录期，公司产生净亏损。2022年度、2023年度及2024年度，拨康视云年内亏损分别约为0.67亿美元、1.29亿美元、0.99亿美元，此外，2024年收益约为1000万美元。","market":"sh","thumbnail":"https://static.tigerbbs.com/03b737852f586e2640047e4e68a010a4","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/03b737852f586e2640047e4e68a010a4"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1308106.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,analysis","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02592"],"gpt_icon":0},{"id":"2545387234","title":"新股消息   眼科生物科技公司拨康视云通过港交所聆讯 三年累计亏损2.95亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545387234","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545387234?lang=zh_cn&edition=fundamental","pubTime":"2025-06-22 10:07","pubTimestamp":1750558034,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/K2LAJUUE0519QIKK.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/K2LAJUUE0519QIKK.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02592"],"gpt_icon":0},{"id":"2545082480","title":"新股消息 | 眼科生物科技公司拨康视云通过港交所聆讯 三年累计亏损2.95亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545082480","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545082480?lang=zh_cn&edition=fundamental","pubTime":"2025-06-22 09:10","pubTimestamp":1750554606,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/K2L7BBM705198UNI.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/K2L7BBM705198UNI.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02592"],"gpt_icon":0},{"id":"2545802904","title":"新股消息 | 眼科生物科技公司拨康视云通过港交所聆讯 三年累计亏损2.95亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545802904","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545802904?lang=zh_cn&edition=fundamental","pubTime":"2025-06-22 09:01","pubTimestamp":1750554090,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据港交所6月20日披露，CLOUDBREAK PHARMA INC.通过港交所上市聆讯，建银国际、华泰国际为其联席保荐人。招股书披露，拨康视云是一间临床阶段眼科生物科技公司，致力于开发各种疗法。财务方面，于往绩记录期，公司产生净亏损。2022年度、2023年度及2024年度，拨康视云年内亏损分别约为0.67亿美元、1.29亿美元、0.99亿美元，此外，2024年收益约为1000万美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062209031197898205&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062209031197898205&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1131","02592","00388","80388"],"gpt_icon":1},{"id":"2545480213","title":"【新股消息 | 眼科生物科技公司拨康视云通过港交所聆讯 三年累计亏损2.95亿美元】智通财经APP获悉，据港交所6月20","url":"https://stock-news.laohu8.com/highlight/detail?id=2545480213","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545480213?lang=zh_cn&edition=fundamental","pubTime":"2025-06-22 09:01","pubTimestamp":1750554090,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["159837","02592","INC","HEXmain"],"gpt_icon":0},{"id":"2545481638","title":"拨康视云“四闯”港交所背后：四年累亏3.3亿美元，股东“内耗”、产品商业化困局待解","url":"https://stock-news.laohu8.com/highlight/detail?id=2545481638","media":"华夏时报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545481638?lang=zh_cn&edition=fundamental","pubTime":"2025-06-22 00:01","pubTimestamp":1750521670,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/K2K7U75T0512D03F.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/K2K7U75T0512D03F.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02592"],"gpt_icon":0},{"id":"2545485360","title":"拨康视云“四闯”港交所背后：四年累亏3.3亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545485360","media":"新浪财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545485360?lang=zh_cn&edition=fundamental","pubTime":"2025-06-21 18:31","pubTimestamp":1750501881,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/K2JL29ST05568W0A.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/K2JL29ST05568W0A.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02592"],"gpt_icon":0},{"id":"2545483120","title":"拨康视云“四闯”港交所背后：四年累亏3.3亿美元，股东“内耗”、产品商业化困局待解","url":"https://stock-news.laohu8.com/highlight/detail?id=2545483120","media":"华夏时报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545483120?lang=zh_cn&edition=fundamental","pubTime":"2025-06-21 17:41","pubTimestamp":1750498860,"startTime":"0","endTime":"0","summary":"但由于尚未有药品上市实现商业化，公司一直处于亏损状态，四年累计亏损3.3亿美元。拨康视云进入成立的第九个年头，但公司产品仍未实现商业化，导致其只能依靠融资来维持运营。招股书显示，拨康视云在上市前的股东架构中，股东数量多达30个。从上述招股书披露来看，公司产品均处于临床试验阶段。与此同时，拨康视云在招股书中披露，预计2025年亏损净额将增加，主要是因为与将作出的以股份为基础的付款增加有关的员工成本预期增加等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-06-21/doc-infavpze5139902.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-06-21/doc-infavpze5139902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HEXmain","02592"],"gpt_icon":0},{"id":"2545488293","title":"Cloudbreak Pharma Inc.（拨康视云）通过港交所上市聆讯","url":"https://stock-news.laohu8.com/highlight/detail?id=2545488293","media":"每日经济新闻","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545488293?lang=zh_cn&edition=fundamental","pubTime":"2025-06-21 16:35","pubTimestamp":1750494907,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/K2JEDFHE0512B07B.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/K2JEDFHE0512B07B.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02592"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":66,"code":"91000000","status":"200"}]}}